Scholars@Duke publication: Hypertension and diabetes and the Fosinopril versus Amlodipine Cardiovascular Events Trial (FACET). More ammunition against surrogate end points.

Hypertension and diabetes and the Fosinopril versus Amlodipine Cardiovascular Events Trial (FACET). More ammunition against surrogate end points.

Publication , Journal Article

Califf, RM; Granger, CB

Published in: Diabetes Care

April 1998

Published version (DOI) Link to item

Duke Scholars

Author Christopher Bull Granger Medicine, Cardiology

Published In

Diabetes Care

DOI

10.2337/diacare.21.4.655

ISSN

0149-5992

Publication Date

April 1998

Volume

21

Issue

4

Start / End Page

655 / 657

Location

United States

Related Subject Headings

Reproducibility of Results
Models, Biological
Hypertension
Humans
Fosinopril
Endocrinology & Metabolism
Diabetic Angiopathies
Clinical Protocols
Calcium Channel Blockers
Antihypertensive Agents

Citation

APA

Chicago

ICMJE

MLA

NLM

Califf, R. M., & Granger, C. B. (1998). Hypertension and diabetes and the Fosinopril versus Amlodipine Cardiovascular Events Trial (FACET). More ammunition against surrogate end points. Diabetes Care, 21(4), 655–657. https://doi.org/10.2337/diacare.21.4.655

Califf, R. M., and C. B. Granger. “Hypertension and diabetes and the Fosinopril versus Amlodipine Cardiovascular Events Trial (FACET). More ammunition against surrogate end points.” Diabetes Care 21, no. 4 (April 1998): 655–57. https://doi.org/10.2337/diacare.21.4.655.

Califf RM, Granger CB. Hypertension and diabetes and the Fosinopril versus Amlodipine Cardiovascular Events Trial (FACET). More ammunition against surrogate end points. Diabetes Care. 1998 Apr;21(4):655–7.

Califf, R. M., and C. B. Granger. “Hypertension and diabetes and the Fosinopril versus Amlodipine Cardiovascular Events Trial (FACET). More ammunition against surrogate end points.” Diabetes Care, vol. 21, no. 4, Apr. 1998, pp. 655–57. Pubmed, doi:10.2337/diacare.21.4.655.

Califf RM, Granger CB. Hypertension and diabetes and the Fosinopril versus Amlodipine Cardiovascular Events Trial (FACET). More ammunition against surrogate end points. Diabetes Care. 1998 Apr;21(4):655–657.

Published In

Diabetes Care

DOI

10.2337/diacare.21.4.655

ISSN

0149-5992

Publication Date

April 1998

Volume

21

Issue

4

Start / End Page

655 / 657

Location

United States

Related Subject Headings

Reproducibility of Results
Models, Biological
Hypertension
Humans
Fosinopril
Endocrinology & Metabolism
Diabetic Angiopathies
Clinical Protocols
Calcium Channel Blockers
Antihypertensive Agents